Voyageur Pharmaceuticals Ltd. (“Voyageur”) has implemented a proven strategy: FROM THE EARTH TO THE BOTTLE.
This strategy is based on controlling all input costs from mineral extraction to pharmaceutical manufacturing and sales.
- Global radiographic contrast media US$7,000,000,000 per year
- USA barium radiographic contrast media US$55,000,000 – US$65,000,000 per year
- USA Iodine radiographic contrast media US$1,500,000,000 per year
Currently, the leaders in the contrast market utilize their barium sulfate to create combined bids of iodine and barium contrast sales. By utilizing barium supply, they leverage this strength to secure high volume iodine sales.
Voyageur, by owning its own ingredient sources, will be able to use its barium as a strategic tool to gain large market share moving forward.
Voyageur expects to achieve rapid market growth by being the only company to be fully integrated.